Javascript must be enabled to continue!
Coordination Compounds for Pharmaceuticals and Drug Delivery Systems
View through CrossRef
Coordination Compounds for Pharmaceuticals and Drug Delivery Systems explores the growing role of metal-based coordination compounds in modern pharmaceutical science. The book combines principles of coordination and medicinal chemistry with drug delivery to explain how metal complexes act as promising therapeutic, diagnostic, and theranostic agents. It highlights the design, synthesis, and unique biological properties of coordination compounds offering innovative solutions for treating and diagnosing a wide range of diseases. The success of clinically approved metal-based drugs such as cisplatin, carboplatin, oxaliplatin, and auranofin, as well as gadolinium-based complexes used as MRI contrast agents is analysed, providing a foundation for the development of next-generation metallopharmaceuticals. In addition to their medicinal potential, the book explores integrating coordination compounds into advanced drug delivery systems, highlighting strategies for improved targeted delivery, bioavailability, and therapeutic efficacy. Key Features:-Provides comprehensive overview of coordination compounds including their design, synthesis, and biological evaluation -Discusses clinically important metal-based drugs and diagnostic agents while exploring their therapeutic applications across antibacterial, anticancer, and antidiabetic agents-Integrated perspectives on coordination and medicinal chemistry with insights into the use of coordination compounds in advanced drug delivery systems
BENTHAM SCIENCE PUBLISHERS
Title: Coordination Compounds for Pharmaceuticals and Drug Delivery Systems
Description:
Coordination Compounds for Pharmaceuticals and Drug Delivery Systems explores the growing role of metal-based coordination compounds in modern pharmaceutical science.
The book combines principles of coordination and medicinal chemistry with drug delivery to explain how metal complexes act as promising therapeutic, diagnostic, and theranostic agents.
It highlights the design, synthesis, and unique biological properties of coordination compounds offering innovative solutions for treating and diagnosing a wide range of diseases.
The success of clinically approved metal-based drugs such as cisplatin, carboplatin, oxaliplatin, and auranofin, as well as gadolinium-based complexes used as MRI contrast agents is analysed, providing a foundation for the development of next-generation metallopharmaceuticals.
In addition to their medicinal potential, the book explores integrating coordination compounds into advanced drug delivery systems, highlighting strategies for improved targeted delivery, bioavailability, and therapeutic efficacy.
Key Features:-Provides comprehensive overview of coordination compounds including their design, synthesis, and biological evaluation -Discusses clinically important metal-based drugs and diagnostic agents while exploring their therapeutic applications across antibacterial, anticancer, and antidiabetic agents-Integrated perspectives on coordination and medicinal chemistry with insights into the use of coordination compounds in advanced drug delivery systems.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
Advances in Coordination Compounds for the Drug Delivery System in the Human Circulatory System
Advances in Coordination Compounds for the Drug Delivery System in the Human Circulatory System
<b>Background:</b> Drug delivery is a significant and evolving research area that
relies on accurately quantifying drugs, particularly when developing drug delivery
sys...
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
BACKGROUND
As of July 2020, a Web of Science search of “machine learning (ML)” nested within the search of “pharmacokinetics or pharmacodynamics” yielded over 100...
A REVIEW ON DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM
A REVIEW ON DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM
The purpose of this review was to select a promising drug delivery system for colon diseases. This review covers the development of Colon Targeted Drug Delivery System (CTDDS) usin...
SAT656 Weight Reduction After 6 Months Of Setmelanotide Treatment In Patients With Hypothalamic Obesity
SAT656 Weight Reduction After 6 Months Of Setmelanotide Treatment In Patients With Hypothalamic Obesity
Abstract
Disclosure: C.L. Roth: Other; Self; Received research support from Rhythm Pharmaceuticals, Inc. A.H. Shoemaker: Advisory Board Member; Self; Received paymen...

